» Articles » PMID: 21906983

Systematic and Quantitative Assessment of the Ubiquitin-modified Proteome

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2011 Sep 13
PMID 21906983
Citations 898
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the diverse biological pathways known to be regulated by ubiquitylation, global identification of substrates that are targeted for ubiquitylation has remained a challenge. To globally characterize the human ubiquitin-modified proteome (ubiquitinome), we utilized a monoclonal antibody that recognizes diglycine (diGly)-containing isopeptides following trypsin digestion. We identify ~19,000 diGly-modified lysine residues within ~5000 proteins. Using quantitative proteomics we monitored temporal changes in diGly site abundance in response to both proteasomal and translational inhibition, indicating both a dependence on ongoing translation to observe alterations in site abundance and distinct dynamics of individual modified lysines in response to proteasome inhibition. Further, we demonstrate that quantitative diGly proteomics can be utilized to identify substrates for cullin-RING ubiquitin ligases. Interrogation of the ubiquitinome allows for not only a quantitative assessment of alterations in protein homeostasis fidelity, but also identification of substrates for individual ubiquitin pathway enzymes.

Citing Articles

A Effector Targets Splicing Factor to Reprogram Alternative Splicing and Regulate Plant Immunity.

Li Y, Kou S Plants (Basel). 2025; 14(4).

PMID: 40006793 PMC: 11859261. DOI: 10.3390/plants14040534.


A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins.

Ganesan I, Kiyokawa H Cancers (Basel). 2025; 17(4).

PMID: 40002221 PMC: 11853300. DOI: 10.3390/cancers17040626.


OTUD7B is a new deubiquitinase targeting p53.

Ding C, Cao L, Wang R, Wu Q, Li M, Zhang J Theranostics. 2025; 15(6):2121-2138.

PMID: 39990225 PMC: 11840744. DOI: 10.7150/thno.103012.


KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism.

Huang H, Ren L, Zhou Y, Chen P, Zhao H, Li S BMC Cancer. 2025; 25(1):311.

PMID: 39984921 PMC: 11844059. DOI: 10.1186/s12885-025-13708-w.


XGBoost-enhanced ensemble model using discriminative hybrid features for the prediction of sumoylation sites.

Khan S, Noor S, Javed T, Naseem A, Aslam F, AlQahtani S BioData Min. 2025; 18(1):12.

PMID: 39901279 PMC: 11792219. DOI: 10.1186/s13040-024-00415-8.


References
1.
Xirodimas D, Sundqvist A, Nakamura A, Shen L, Botting C, Hay R . Ribosomal proteins are targets for the NEDD8 pathway. EMBO Rep. 2008; 9(3):280-6. PMC: 2267383. DOI: 10.1038/embor.2008.10. View

2.
Olsen J, Vermeulen M, Santamaria A, Kumar C, Miller M, Jensen L . Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010; 3(104):ra3. DOI: 10.1126/scisignal.2000475. View

3.
Xu G, Paige J, Jaffrey S . Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat Biotechnol. 2010; 28(8):868-73. PMC: 2946519. DOI: 10.1038/nbt.1654. View

4.
Skaug B, Chen Z . Emerging role of ISG15 in antiviral immunity. Cell. 2010; 143(2):187-90. PMC: 2981609. DOI: 10.1016/j.cell.2010.09.033. View

5.
Jones J, Wu K, Yang Y, Guerrero C, Nillegoda N, Pan Z . A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. J Proteome Res. 2008; 7(3):1274-87. PMC: 2676899. DOI: 10.1021/pr700749v. View